MET-2: Clinical Trials

6 trials of MET-2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown, 1 withdrawn. 3 Phase 1, 2 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 22Unknown 1, Withdrawn 1
Early Phase 11Completed 1

Follow MET-2: new trials by email Literature Review of MET-2 trials Research Report on MET-2

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation
MET-2, Placebo - Gram-negative Bacteremia, Microbial Colonization
Phase 2WithdrawnUniversity Health Network, Toronto2026-07-012026-03-12
The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression
MET-2, Placebo - Major Depressive Disorder, Anxiety
Phase 2UnknownNuBiyota602021-04-012021-05-11
The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder
MET-2 - Depression, Anxiety
Phase 1CompletedNuBiyota212019-05-162020-08-11
Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC)
MET-2, Placebo oral capsule - Ulcerative Colitis
Phase 1CompletedNuBiyota112019-02-042021-05-03
Safety and Efficacy of MET-3 in Obese Human Subjects
MET-2 - Obesity
Early Phase 1CompletedNuBiyota152018-10-012020-08-11
MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)
MET-2, Vancomycin - Clostridium Difficile Infection
Phase 1CompletedNuBiyota192017-10-272020-08-11

Conditions studied

Anxiety Disorders (2)  ·  Bacteremia (1)  ·  Clostridium Infections (1)  ·  Colitis, Ulcerative (1)  ·  Communicable Diseases (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Infections (1)  ·  Obesity (1)  ·  Reinfection (1)

Sponsors

NuBiyota (5)  ·  University Health Network, Toronto (1)

Countries

Canada (6)

Top investigators

Allan H Steinhart, MD (1)  ·  Bryan Coburn, MD, PhD (1)  ·  Dina Kao, MD (1)  ·  Roumen Milev, MD/PhD (1)  ·  Thomas MS Wolever, MD/PhD (1)

Results publications

PMID 33631102, PMID 34550085, PMID 35060914, PMID 40116713